Cite
HARVARD Citation
Georgakopoulos, J. et al. (2020). Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study. Journal of the European Academy of Dermatology and Venereology. pp. e416-e418. [Online].